|

Belvarafenib Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Also known as: HM95573

Pipeline

Phase 2: 2

Top Sponsors

  • Samsung Medical Center1
  • Hanmi Pharmaceutical Company Limited1

Indications

  • Cancer2
  • Advanced or Metastatic Melanoma1
  • Metastatic Brain Tumor1
  • Primary Brain Tumor1

Other2 trials

Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors
Phase 2
Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.